Curated News
By: NewsRamp Editorial Staff
August 21, 2025
Creative Biogene Launches Advanced Antibody Purification Platform
TLDR
- Creative Biogene's expanded antibody purification platform gives researchers a competitive edge with high-yield, high-purity antibodies from scalable, customizable protocols.
- The platform uses capture, intermediate, and polishing steps with Protein A/G/L resins, ion exchange, and size exclusion chromatography for over 95% purity.
- This technology empowers biotechnology research with accessible, high-quality tools to advance scientific discovery and improve healthcare solutions worldwide.
- Creative Biogene's purification system features compact chromatography columns and filtration options that ensure fast turnaround between experimental runs.
Impact - Why it Matters
This development matters significantly because high-quality antibody purification is fundamental to biomedical research, drug development, and diagnostic testing. Inaccurate or inconsistent antibody preparations can compromise research validity, delay drug discovery timelines, and affect diagnostic accuracy. Creative Biogene's platform addresses these challenges by providing researchers and biotech companies with reliable, scalable purification technology that ensures consistent results. This advancement accelerates scientific discovery, reduces development costs, and ultimately contributes to faster development of new therapeutics and diagnostics that can improve patient outcomes and advance medical science.
Summary
Creative Biogene has launched an expanded antibody purification platform that revolutionizes how researchers and biotechnology companies produce high-quality antibodies. The New York-based company's comprehensive system offers a streamlined workflow with scalable protocols capable of handling various expression sources, addressing the growing demand for consistent and efficient antibody preparations. This innovative platform demonstrates Creative Biogene's commitment to empowering the biotechnology sector with accessible, high-quality purification technology that delivers exceptional results.
The platform features a sophisticated multi-step purification process that includes capture, intermediate purification, and polishing stages. It utilizes Protein A/G/L resins for Fc-binding antibodies, ion exchange chromatography for charge-based purification, and size exclusion chromatography for aggregate removal, consistently achieving final antibody purity exceeding 95%. The system also incorporates orthogonal processes like hydrophobic interaction chromatography and multimodal techniques, supported by comprehensive quality control services including SDS-PAGE, SEC-HPLC, and endotoxin testing with detailed Certificate of Analysis reports.
Supported by state-of-the-art equipment including compact chromatography columns, process chromatography systems at laboratory and pilot scales, and advanced filtration systems, the platform offers complete flexibility and fast turnaround times. According to Marcia Brady's Chief Expert, the platform's main value lies in its well-balanced throughput and reproducibility across various scales and antibody targets. Creative Biogene plans future enhancements with increased automation and scalability, positioning this technology as essential for antibody candidate development, assay optimization, kit component production, and research reagent applications.
Source Statement
This curated news summary relied on content disributed by 24-7 Press Release. Read the original source here, Creative Biogene Launches Advanced Antibody Purification Platform
